用於COVID-19、Flu A&B 以及 RSV綜合診斷的抗體和抗原
|
有鑑於 COVID-19 和季節性流感的症狀相似，國際預防傳染病組織建議透過多項檢測來加強監測，如COVID-19 和其他呼吸道疾病。由於 SARS-CoV-2 與其他呼吸道疾病病毒共同傳播，因此如果能使用綜合診斷 COVID-19 & Flu & RSV 的檢測組合，對於疾病的控制和臨床治療是非常重要。 亞旭代理的Creative Diagnostics 提供廣泛的單株抗體和天然抗原，可以用在快速檢測 SARS-CoV-2、A流感、 B流感 RSV感染。
|
|
|
|
●
|
單株抗體對可以用於高靈敏性的ELISA和LFIA
|
|
●
|
天然的抗原可用於免疫檢測開發
|
|
|
特色產品
|
|
Anti-SARS-CoV-2 Nucleoprotein Monoclonal Antibodies
|
|
|
|
SARS-CoV-2 Native Antigens
|
|
DAG-WT603
|
Inactivated SARS-CoV-2 Variant B.1.1.529 Culture Fluid
|
|
DAGC473
|
Inactivated SARS-CoV-2 (Isolate: BetaCoV/Wuhan/IPBCAMS-WH-01/2019) Culture Fluid
|
|
|
Anti-IAV Monoclonal antibodies
|
|
|
|
Anti-IBV Monoclonal antibodies
|
|
|
|
Anti-RSV Monoclonal Antibodies
|
|
|
|
更多資訊
|
|
|
|
SARS-CoV-2 Spike Stable Cell Line
|
|
|
The SARS-CoV-2 spike CHO-K1 cell line has been developed by the stable transfection of the SARS-CoV-2 spike protein plasmid. SARS-CoV-2 spike CHO-K1 cell line provides consistent levels of expression of the SARS-CoV-2 spike protein on the cell surface.
Delta, Kappa, and Lambda SARS-CoV-2 Pseudotyped Lentivirus Now Available.
|
|
|
Learn more
|
|
|
|
|
|
|
SARS-CoV-2 Neutralizing Antibody ELISA Kit
|
|
|
With the demand for vaccine development, Creative Diagnostics has developed two ELISA kits for the qualitative detection of SARS-CoV-2 neutralizing antibodies in serum and plasma. Our competitive assay format measures neutralizing antibodies of the SARS-CoV-2 spike RBD and ACE2 interaction in human plasma and serum.
|
|
|
Learn more
|
|
|
|
|
